Craig-Hallum Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Announces Target Price $27

Moomoo NewsApr 2 03:34 ET · Ratings

Eton Sells Ex-U.S. Rights for Hormone Disorder Therapy to Esteve Pharma

Seeking AlphaApr 1 12:18 ET

Express News | Eton Pharmaceuticals Inc - Esteve to Pay EUR4 Million up Front for Increlex Rights - SEC Filing

ReutersApr 1 07:16 ET

Eton Pharmaceuticals Out-Licenses International Rights to Increlex

Eton PharmaceuticalApr 1 00:00 ET

H.C. Wainwright Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Maintains Target Price $33

Moomoo NewsMar 20 03:32 ET · Ratings

B.Riley Financial Maintains Eton Pharmaceutical(ETON.US) With Buy Rating, Raises Target Price to $24

Moomoo NewsMar 20 03:32 ET · Ratings